期刊
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
卷 64, 期 3, 页码 -出版社
AMER SOC MICROBIOLOGY
DOI: 10.1128/AAC.01538-19
关键词
Aotus monkeys; JPC-3210; Plasmodium falciparum; Plasmodium vivax; antimalarial drug discovery; in vitro drug susceptibility; pharmacokinetics
资金
- Australian Defence Organisation
- Jacobus Pharmaceutical Company, Inc
- USAMRMC (US Army Medical Research and Materiel Command) Grant [W81XWH-07-044]
Nonimmune Aotus monkeys infected with Plasmodium falciparum and Plasmodium vivax were cured of their infections when treated with a single oral dose of 5 mg/kg and 10 mg/kg of the 2-aminomethylphenol, JPC-3210, respectively. Corresponding mean blood elimination half-lives of JPC-3210 were lengthy at 19.1 days and 20.5 days, respectively. This in vivo potency and lengthy half-life supports the further development of JPC-3210 as a promising, long-acting blood schizontocidal antimalarial for malaria treatment and prevention.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据